Positive Interim Results from IceCure Medical’s ICE3 Clinical Trial for Breast Cancer Treatment by Freezing with the ProSense® Cryoablation System Presented at the 2021 ASBrS Meeting
May 3, 2021
CAESAREA, Israel, May 3, 2021 — IceCure Medical Ltd. (TASE: ICCM) (“IceCure” or the “Company”), developer of the minimally invasive cryoablation ProSense® System that destroys